Source comparison
CJC-1295 no DAC vs GHRP-6 Acetate — Peptide Comparison
This table compares the core pharmacological characteristics, receptor mechanisms, and practical research considerations for CJC-1295 no DAC and GHRP-6 Acetate. CJC-1295 no DAC GHRH receptor agonist. Amplifies natural GH pulses 30 minutes (plasma clearance) 1–
This comparison does not assign a generated winner or score.
- This table compares the core pharmacological characteristics, receptor mechanisms, and practical research considerations for CJC-1295 no DAC and GHRP-6 Acetate.
- CJC-1295 no DAC
- GHRH receptor agonist. Amplifies natural GH pulses
- 30 minutes (plasma clearance)
- 1–3x daily, timed to natural GH cycles
- None
- Best for preserving physiological GH rhythm while amplifying pulse amplitude. Requires intact pituitary function
- GHRP-6 Acetate
- Ghrelin receptor agonist. Triggers immediate GH spike independent of circadian rhythm
- 20–30 minutes
- 2–3x daily, fasted state required
- Strong. Increases appetite 20–40 min post-injection via NPY/AgRP pathways
- Best for forced GH secretion in metabolically compromised models or when endogenous GHRH signaling is suppressed
- Synergistic Stack
- Dual GHRH-R + GHS-R1a activation with somatostatin suppression
- N/A. Combination therapy
- 2–3x daily (100 mcg CJC + 200 mcg GHRP-6)
- Moderate. GHRP-6 appetite effect partially offset by CJC timing
- Produces 2.5–3.5× higher GH output than sum of individual peptides. Most potent approach for maximizing IGF-1 elevation